The Africa Health Business Symposium 2026 is a critical event that brings together stakeholders to address the pressing issue of equitable HPV prevention and cervical cancer screening in Kenya. The event highlights the persistent disparities in cervical cancer rates among women in low- and middle-income countries, with Kenya being no exception. Despite the availability of effective tools like HPV vaccination, screening, and early treatment, coverage gaps remain a major barrier to progress. This article delves into the key developments and challenges in Kenya's journey towards cervical cancer elimination, emphasizing the need for a comprehensive and equitable approach.
One of the most significant advancements is the transition to a single-dose HPV vaccination schedule, which simplifies logistics and reduces costs. This shift has the potential to rapidly expand coverage and improve efficiency within immunization programs, especially when combined with school-based programs and community outreach. Additionally, the expansion of HPV DNA testing and self-sampling approaches is revolutionizing early detection, addressing barriers associated with facility-based screening.
However, several critical gaps persist. Low screening coverage and late-stage diagnosis are major concerns, with only 10% of women in Kenya being screened. This leads to limited treatment options and increased mortality. The absence of clear policy direction for adult women in vaccination strategies is another challenge, as emerging global guidance supports their inclusion. Persistent inequities across counties and vulnerable populations further exacerbate the issue, requiring a multi-sectoral investment and whole-of-society engagement.
The roundtable will focus on practical, scalable solutions to accelerate progress. Community and civil society play a crucial role in driving equity by bridging the gap between national strategies and lived realities. Scaling proven community-led models, such as HPV self-sampling and outreach screening, is essential. Public-private collaboration is also vital, with clearly defined roles and opportunities to harness private sector capacity in diagnostics, laboratory networks, and service delivery.
The session will also address the disconnect between community-level demand and national financing mechanisms. Aligning community-identified needs with national policy priorities and budget allocations is crucial. Integrating cervical cancer services into Universal Health Coverage (UHC) frameworks and strengthening strategic purchasing mechanisms will ensure adequate financing. Additionally, strengthening the continuum of care from prevention to treatment and survivorship is essential to eliminate cervical cancer.
In conclusion, the Africa Health Business Symposium 2026 is a pivotal moment for Kenya to accelerate progress towards cervical cancer elimination. By addressing the critical gaps and implementing practical solutions, Kenya can ensure that every woman, regardless of location or socio-economic status, can access effective HPV prevention, screening, and care. The event serves as a catalyst for action, generating insights that can inform national and sub-national strategies, investment priorities, and partnership models.
